A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD
Trial details
- Registry ID
- NCT05686044
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
Also recorded as Posiphen Tartrate
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate ADNCT05686044 | ANVS | Phase 2, Phase 3 | Completed | 2024-02-13Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |